These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 34756240)
21. Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System. Nogueira Guerra L; Herdeiro MT; Ribeiro-Vaz I; Clérigo MI; Rocha C; Araújo A; Pêgo A; Rebelo Gomes E Expert Opin Drug Saf; 2015; 14(12):1805-13. PubMed ID: 26549822 [TBL] [Abstract][Full Text] [Related]
22. Nurses' spontaneous reporting of adverse drug reactions: expert review of routine reports. Mendes D; Alves C; Batel Marques F J Nurs Manag; 2014 Apr; 22(3):322-30. PubMed ID: 24754750 [TBL] [Abstract][Full Text] [Related]
23. An observational study to compare the contents and quality of information furnished in CDSCO ADR reporting form, yellow card, medwatch and blue form by the healthcare professionals. Rehan HS; Chopra D; Holani SN; Mishra R Int J Risk Saf Med; 2014; 26(1):1-8. PubMed ID: 24796346 [TBL] [Abstract][Full Text] [Related]
24. Adverse drug reactions in adolescents: a review of reporting to a national pharmacovigilance system. Rebelo Gomes E; Ribeiro-Vaz I; Santos CC; Herdeiro MT Expert Opin Drug Saf; 2020 Jul; 19(7):915-922. PubMed ID: 32422079 [TBL] [Abstract][Full Text] [Related]
25. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. Le TT; Nguyen TTH; Nguyen C; Tran NH; Tran LA; Nguyen TB; Nguyen N; Nguyen HA J Clin Pharm Ther; 2020 Feb; 45(1):122-127. PubMed ID: 31486525 [TBL] [Abstract][Full Text] [Related]
26. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
27. [Safety of SGLT2 inhibitors. A review of the adverse drug reactions registered in a national database]. Esteban-Jiménez O; Navarro-Pemán C; Urieta-González L Semergen; 2018; 44(1):23-29. PubMed ID: 29183654 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of completeness of suspected adverse drug reaction reports submitted to the mexican national pharmacovigilance centre: a cross-sectional period-prevalence study. Sánchez-Sánchez B; Altagracia-Martínez M; Kravzov-Jinich J; Moreno-Bonett C; Vázquez-Moreno E; Martínez-Núñez JM Drug Saf; 2012 Oct; 35(10):837-44. PubMed ID: 22924896 [TBL] [Abstract][Full Text] [Related]
29. The quality of spontaneous adverse drug reaction reports from the pharmacovigilance centre in western China. Niu R; Xiang Y; Wu T; Zhang Z; Chen Y; Feng B Expert Opin Drug Saf; 2019 Jan; 18(1):51-58. PubMed ID: 30574811 [TBL] [Abstract][Full Text] [Related]
30. Detection of adverse drug reactions through the minimum basic data set. Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432 [TBL] [Abstract][Full Text] [Related]
31. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
32. Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting. Hanafi S; Torkamandi H; Hayatshahi A; Gholami K; Javadi M Iran J Nurs Midwifery Res; 2012 Jan; 17(1):21-5. PubMed ID: 23492864 [TBL] [Abstract][Full Text] [Related]
33. Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia. Ali MD; Hassan YA; Ahmad A; Alaqel O; Al-Harbi H; Al-Suhaimi NM Curr Drug Saf; 2018; 13(1):21-25. PubMed ID: 29256354 [TBL] [Abstract][Full Text] [Related]
34. Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal. Ribeiro-Vaz I; Santos C; da Costa-Pereira A; Cruz-Correia R Drug Saf; 2012 May; 35(5):387-94. PubMed ID: 22468615 [TBL] [Abstract][Full Text] [Related]
35. Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBase. Berhe DF; Juhlin K; Star K; Beyene KG; Dheda M; Haaijer-Ruskamp FM; Taxis K; Mol PG Trop Med Int Health; 2015 Jun; 20(6):797-806. PubMed ID: 25704305 [TBL] [Abstract][Full Text] [Related]
36. Headache as an Adverse Reaction to the Use of Medication in the Elderly: A Pharmacovigilance Study. Monteiro C; Dias B; Vaz-Patto M Int J Environ Res Public Health; 2021 Mar; 18(5):. PubMed ID: 33799926 [TBL] [Abstract][Full Text] [Related]
37. Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting. Aung AK; Tang MJ; Adler NR; de Menezes SL; Goh MSY; Tee HW; Trubiano JA; Puy R; Zubrinich CM; Graudins LV J Clin Pharmacol; 2018 Oct; 58(10):1332-1339. PubMed ID: 29733431 [TBL] [Abstract][Full Text] [Related]
38. First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals. Durrieu G; Palmaro A; Pourcel L; Caillet C; Faucher A; Jacquet A; Ouaret S; Perault-Pochat MC; Kreft-Jais C; Castot A; Lapeyre-Mestre M; Montastruc JL; Drug Saf; 2012 Oct; 35(10):845-54. PubMed ID: 22967189 [TBL] [Abstract][Full Text] [Related]
39. Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants. Kiguba R; Karamagi C; Waako P; Ndagije HB; Bird SM BMJ Open; 2014 Nov; 4(11):e005869. PubMed ID: 25421337 [TBL] [Abstract][Full Text] [Related]
40. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria. Adisa R; Adeniyi OR; Fakeye TO Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]